Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy

by Amol Mehta, Chidiebere U. Awah, Adam M. Sonabend
Published 2018-06-01

The possibility of cancer immune editing in gliomas. A critical review

by Víctor A. Arrieta, Bernardo Cacho-Díaz, Junfei Zhao, Raul Rabadan, Li Chen, Adam M. Sonabend
Published 2018-07-01

Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype.

by Liang Lei, Adam M Sonabend, Paolo Guarnieri, Craig Soderquist, Thomas Ludwig, Steven Rosenfeld, Jeffrey N Bruce, Peter Canoll
Published 2011-01-01

Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm

by Hongxu Ding, Eugene F. Douglass, Adam M. Sonabend, Angeliki Mela, Sayantan Bose, Christian Gonzalez, Peter D. Canoll, Peter A. Sims, Mariano J. Alvarez, Andrea Califano
Published 2018-04-01

Assessing the Safety of Craniotomy for Resection of Primary Central Nervous System Lymphoma: A Nationwide Inpatient Sample Analysis

by Jonathan Yun, Jingyan Yang, Michael Cloney, Amol Mehta, Suprit Singh, Fabio Massaiti Iwamoto, Alfred I. Neugut, Alfred I. Neugut, Alfred I. Neugut, Adam M. Sonabend
Published 2017-09-01

Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.

by Anne L Baldock, Sunyoung Ahn, Russell Rockne, Sandra Johnston, Maxwell Neal, David Corwin, Kamala Clark-Swanson, Greg Sterin, Andrew D Trister, Hani Malone, Victoria Ebiana, Adam M Sonabend, Maciej Mrugala, Jason K Rockhill, Daniel L Silbergeld, Albert Lai, Timothy Cloughesy, Guy M McKhann, Jeffrey N Bruce, Robert C Rostomily, Peter Canoll, Kristin R Swanson
Published 2014-01-01